Indirect immunoassay for dioxinlike compounds
AssigneeCornell Research Foundation, Inc.
InventorsJohn G. Babish, Sakina El-Tom, Xinfang Ma, Goeffrey Wheelock
Life of this patent
Estimating the term…
Abstract
This invention relates to the determination of in vivo exposure to dioxinlike compounds and the in vitro quantitation of dioxinlike compounds based on protein tyrosine phosphorylation as mediated by the Ah receptor. The extent of protein tyrosine phosphorylation is determined by monoclonal antibodies to protein tyrosine phosphate. The amount and nature of protein tyrosylphosphate is quantitatively related to the in vivo or in vitro concentration of dioxin to which animals or cells were exposed. This method permits detection of dioxinlike compounds at concentrations in the parts per trillion and parts per billion range.
Claims2
A method of detecting, in a test sample, polychlorinated dibenzodioxins, polychlorinated dibenzofurans, and structural analogs thereof which exhibit biological activity of polychlorinated dibenzodioxins and polychlorinated dibenzofurans, said biological activity comprising phosphorylation of tyrosine residues of S-9 supernatant fraction proteins, said method comprising:
- administering the test sample to a female C57BL/6 mouse at a dose of 2.0 .mu.g/kg or less of the polychlorinated dibenzodioxins, polychlorinated dibenzofurans, and structural analogs thereof;
- examining immunologically the mouse's hepatic S-9 supernatant fraction for phosphorylation of tyrosine residues of the S-9 supernatant fraction proteins;
- and
- correlating the phosphorylation level to the presence of polychlorinated dibenzodioxins, polychlorinated dibenzofurans, and structural analogs thereof in the test sample.
A method of detecting, in a test sample, polychlorinated dibenzodioxins, polychlorinated dibenzofurans, and structural analogs thereof which exhibit biological activity of polychlorinated dibenzodioxins and polychlorinated dibenzofurans, said biological activity comprising phosphorylation of tyrosine residues of S-9 supernatant fraction proteins, said method comprising:
- administering the test sample to an X3 lymphoblastoma cell line at a concentration of 1.0 nm or less of the polychlorinated dibenzodioxins, polychlorinated dibenzofurans, and structural analogs thereof;
- lysing cells of the cell line to form a cell lysate;
- examining immunologically the cell lysate's S-9 supernatant fraction for phosphorylation of tyrosine residues of the S-9 supernatant fraction proteins;
- and
- correlating the phosphorylation level to the presence of polychlorinated dibenzodioxins, polychlorinated dibenzofurans, and structural analogs thereof in the test sample.
Dependencies are inferred from the claim text.